Salix Pharmaceuticals Ltd. (SLXP) [Chart - Analysis - News] lost some ground during trading yesterday, but it appears there is some bullish pressure building up in the background. Looking at ...
RALEIGH, NC--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that Salix and Norgine BV have entered into an agreement with Novel Laboratories, Inc. to settle patent ...
Salix Pharmaceuticals (SLXP) Announces Settlement of Pending Litigation Regarding MOVIPREP - StreetInsider.com
Salix Reveals Settlement Of Pending Litigation Regarding MOVIPREP - Quick Facts - RTT News
By Chip Brian When Salix Pharmaceuticals (NASDAQ:SLXP) reported earnings 11 days ago on August 09, 2010, analysts, on average, expected the company to report earnings of $0.10 on sales of $94 ...
NEW YORK (Market Intellisearch) -- Shares of SLXP crossed below the critical 50-day moving average of $40.35. The location of a stock price when analyzed against the moving average can aid in ...
By Chip Brian Salix Pharmaceuticals (NASDAQ:SLXP) traded in a range yesterday that spanned from a low of $39.86 to a high of $41.50. Yesterday, the shares gained 2.00%, which took the trading ...
NEW YORK (Market Intellisearch) -- Today's trading activities for Salix Pharmaceuticals Ltd. stock may signal that the shares may continue to head lower in the foreseeable future assuming that the ...
NEW YORK (Market Intellisearch) -- Today the stock price of Salix Pharmaceuticals Ltd. crossed below the much followed 50-day moving average. The moving average crossover was accompanied by ...
By Chip Brian Below are the top five companies in the Healthcare sector as measured by relative performance. Lowest relative performance is a comparison between a share and its peers made to ...
Unusual volume of call and put contracts crossed the tape today. Total of 1,818 call contracts and 913 put contracts were traded in the marketplace. Today's traded Put/Call ratio is 0.50. There ...
By Chip Brian Salix Pharmaceuticals (NASDAQ:SLXP) traded in a range yesterday that spanned from a low of $41.17 to a high of $43.14. Yesterday, the shares gained 3.46%, which took the trading ...
MBIA Inc. (NYSE: MBI) said late Monday that its second-quarter net income rose 44%, driven primarily by a $1.5 billion pre-tax unrealized gain on insured credit derivatives. Net income jumped to ...
Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP | PowerRating) said it expects a third quarter loss of approximately $0.13 per share with product revenue revenue of approximately $73.0 million. The ...
USA 
Summary
Profile
Volatility
History
News
Corporate Filings
Ownership Records
Discussion
